Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Acromegaly × Octreotide × CNS × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 1 CNS 1

Conditions

Meningioma 2 Zollinger-Ellison Syndrome 1 Somatostatinoma 1 Pituitary Neoplasms 1 Paraganglioma 1 Insulinoma 1 Glucagonoma 1 Carcinoma, Merkel Cell 1 Carcinoma, Medullary 1 Brain Neoplasms 1 Acromegaly 1

Interventions

pegvisomant 1 Octreotide 1 Cabergoline 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00376064 2017-03-06

Efficacy of Octreotide Acetate and Cabergoline in Patients With Acromegaly

Novartis

Phase 4 Completed

Acromegaly, Brain Neoplasms, Pituitary Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡